Given CA9’s established role in regulating extracellular pH homeostasis, promoting EMT, and facilitating tumor invasiveness, its downregulation by ICT likely represents a key mechanism underlying ICT’s ability to inhibit HCC cell proliferation and migration, thereby contributing to its antitumor efficacy. The gene discussed is CA9; the disease is hepatocellular carcinoma.